Indivior Pharmaceuticals (INDV) Income towards Parent Company (2024 - 2026)
Indivior Pharmaceuticals' Income towards Parent Company came in at $122 million for Q2 2026, up 577.8% from $18 million a year earlier and up 37.1% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Income towards Parent Company (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Indivior Pharmaceuticals reported Income towards Parent Company of $355 million, up 228.7% year-over-year; for FY2025, it came in at $210 million.
- Income towards Parent Company carries a four-year compound annual growth rate of 0.6% (FY2021 to FY2025).
- Going back by year, Income towards Parent Company was $7 million in FY2024, -$126 million in FY2023, -$42 million in FY2022 and $205 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Income towards Parent Company in data going back to Q1 2024.
- Year-over-year, Income towards Parent Company has increased for four consecutive quarters, with growth averaging 224.2% over the last five quarters.
- Business Quant data shows INDV's Income towards Parent Company at $89 million (Q1 2026), $102 million (Q4 2025) and $42 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Indivior Pharmaceuticals | 4.21 Bn | 3.18 Bn | 294.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.00 Mn |
| Mar 31, 2026 | 89.00 Mn |
| Dec 31, 2025 | 102.00 Mn |
| Sep 30, 2025 | 42.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | 47.00 Mn |
| Dec 31, 2024 | 21.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | -97.00 Mn |
| Mar 31, 2024 | 61.00 Mn |
API Access
Indivior Pharmaceuticals Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();